Skip to main content

Advertisement

Log in

Mechanistic details for anthraniloyl transfer in PqsD: the initial step in HHQ biosynthesis

  • Original Paper
  • Published:
Journal of Molecular Modeling Aims and scope Submit manuscript

Abstract

PqsD mediates the conversion of anthraniloyl-coenzyme A (ACoA) to 2-heptyl-4-hydroxyquinoline (HHQ), a precursor of the Pseudomonas quinolone signal (PQS) molecule. Due to the role of the quinolone signaling pathway of Pseudomonas aeruginosa in the expression of several virulence factors and biofilm formation, PqsD is a potential target for controlling this nosocomial pathogen, which exhibits a low susceptibility to standard antibiotics. PqsD belongs to the β-ketoacyl-ACP synthase family and is similar in structure to homologous FabH enzymes in E. coli and Mycobacterium tuberculosis. Here, we used molecular dynamics simulations to obtain the structural position of the substrate ACoA in the binding pocket of PqsD, and semiempirical molecular orbital calculations to study the reaction mechanism for the catalytic cleavage of ACoA. Our findings suggest a nucleophilic attack of the deprotonated sulfur of Cys112 at the carbonyl carbon of ACoA and a switch in the protonation pattern of His257 whereby Nδ is protonated and the proton of Nε is shifted to the sulfur of CoA during the reaction. This is in agreement with the experimentally determined decreased catalytic activity of the Cys112Ser mutant, whereas the Cys112Ala, His257Phe, and Asn287Ala mutants are all inactive. ESI mass-spectrometric measurements of the Asn287Ala mutant show that anthraniloyl remains covalently bound to Cys112, thus further supporting the inference from our computed mechanism that Asn287 does not take part in the cleavage of ACoA. Since this mutant is inactive, we suggest instead that Asn287 must play an essential role in the subsequent formation of HHQ in vitro.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4a–d

Similar content being viewed by others

References

  1. Heeb S, Fletcher MP, Chhabra SR, Diggle SP, Williams P, Cámera M (2011) Quinilones: From antibiotics to autoinducers. FEMS Microbiol Rev 35:247–274

  2. Rasmussen TB, Givskov M (2006) Quorum sensing inhibitors: a bargain of effects. Microbiology 152:895–904

  3. Rasmussen TB, Givskov M (2006) Quorum-sensing inhibitors as anti-pathogenic drugs. Int J Med Microbiol 296:149–161

  4. Lu C, Kirsch B, Zimmer C, de Jong JC, Henn C, Maurer CK, Müsken M, Häussler S, Steinbach A, Hartmann RW (2012) Discovery of antagonists of PqsR, a key player in 2-alkyl-4-quinolone-dependent quorum sensing in Pseudomonas aeruginosa. Chem Biol 19:381–390

  5. Lu C, Maurer CK, Kirsch B, Steinbach A, Hartmann RW (2014) Overcoming the unexpected functional inversion of a PqsR antagonist in Pseudomonas aeruginosa: an in vivo potent antivirulence agent targeting PQS quorum sensing. Angew Chem Int Ed 53:1109–1112

  6. Klein T, Henn C, de Jong JC, Zimmer C, Kirsch B, Maurer CK, Pistorius D, Müller R, Steinbach A, Hartmann RW (2012) Identification of small-molecule antagonists of the Pseudomonas aeruginosa transcriptional regulator PqsR: biophysically guided hit discovery and optimization. ACS Chem Biol 7:1496–1501

  7. Zender M, Klein T, Henn C, Kirsch B, Maurer CK, Kail D, Ritter C, Dolezal O, Steinbach A, Hartmann RW (2013) Discovery and biophysical characterization of 2‑amino-oxadiazoles as novel antagonists of PqsR, an important regulator of Pseudomonas aeruginosa virulence. J Med Chem 56:6761–6774

  8. Ilangovan A, Fletcher M, Rampioni G, Pustelny C, Rumbaugh K, Heeb S, Cámara M, Truman A, Chhabra SR, Emsley J, Williams P (2013) Structural basis for native agonist and synthetic inhibitor recognition by the Pseudomonas aeruginosa quorum sensing regulator PqsR (MvfR). PLoS Pathog 9(7):e10035089

  9. Storz MP, Maurer CK, Zimmer C, Wagner N, Brengel C, de Jong JC, Lucas S, Müsken M, Häussler S, Steinbach A, Hartmann RW (2012) Validation of PqsD as an anti-biofilm target in Pseudomonas aeruginosa by development of small-molecule inhibitors. J Am Chem Soc 134:16143–161469

  10. Allesen-Holm M, Barken KB, Yang L, Klausen M, Webb JS, Kjelleberg S, Molin S, Givskov M, Tolker-Nielsen T (2006) A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol 59:1114–1128

  11. Lesic B, Lépine F, Déziel E, Zhang J, Zhang Q, Padfield K, Castonguay MH, Milot S, Stachel S, Tzika AA, Tompkins RG, Rahme LG (2007) Inhibitors of pathogen intercellular signals as selective anti-infective compounds. PLoS Pathog 3:1229–1239

  12. Pistorius D, Ullrich A, Lucas S, Hartmann RW, Kazmaier U, Müller R (2011) Biosynthesis of 2-alkyl-4(1H)-quinolones in Pseudomonas aeruginosa: potential for therapeutic interference with pathogenicity. ChemBioChem 12:850–853

  13. Huse H, Whiteley M (2011) 4-Quinolones: smartphones of the bacterial world. Chem Rev 111:152–159

  14. Gallagher LA, McKnight SL, Kuznetsova MS, Pesci EC, Manoil C (2002) Functions required for extracellular quinolone signalling by Pseudomonas aeruginosa. J Bacteriol 184:6472–6480

  15. Weidel E, de Jong JC, Brengel C, Storz MP, Braunshausen A, Negri M, Plaza A, Steinbach A, Müller R, Hartmann RW (2013) Structure optimization of 2‑benzamidobenzoic acids as PqsD inhibitors for Pseudomonas aeruginosa infections and elucidation of binding mode by SPR, STD NMR, and molecular docking. J Med Chem 56:6146–6155

  16. Sahner JS, Brengel C, Storz MP, Groh M, Plaza A, Müller R, Hartmann RW (2013) Combining in silico and biophysical methods for the development of Pseudomonas aeruginosa quorum sensing inhibitors: an alternative approach for structure-based drug design. J Med Chem 56:8656–8664

  17. Bera AK, Atansova V, Robinson H, Eisenstein E, Coleman JP, Pesci EC, Parsons JF (2009) Structure of PqsD, a Pseudomonas quinolone signal biosynthetic enzyme, in complex with anthranilate. Biochemistry 48:8644–8655

  18. Hutter MC, Helms V (2002) Mechanism of phosphorylation of natural nucleosides and anti-HIV analogs by nucleoside diphosphate kinase is independent of their sugar substituents. ChemBioChem 3:643–651

  19. Seeliger D, de Groot BL (2010) Conformational transitions upon ligand binding: holo-structure prediction from apo conformations. PLoS Comput Biol 6:e1000634

  20. Chemical Computing Group, Inc. (2010) Molecular Operating Environment (MOE). Chemical Computing Group, Inc., Montreal

  21. Case DA, Darden TA, Cheatham TE III, Simmerling CL, Wang J (2010) AMBER 11. University of California, San Francisco

  22. Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simerling C (2006) Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 65:712–725

  23. Andersen HC (1983) Rattle: a ‘velocity’ version of the Shake algorithm for molecular dynamics calculations. J Comput Phys 52:24–34

  24. Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N-log(N) method for Ewald sums in large systems. J Chem Phys 98:10089–10092

  25. Rauhut G, Alex A, Chandrasekhar J, Steinke T, Sauer W, Beck B, Hutter M, Gedeck P, Clark T (1997) VAMP version 6.5. Oxford Molecular, Erlangen

  26. Dewar MJS, Zoebisch EG, Healy EF, Stewart JJP (1985) The Development and use of quantum-mechanical molecular-model: 76. AM1—a new general-purpose quantum-mechanical molecular-model. J Am Chem Soc 107:3902–3909

  27. Vernet T, Tessier DC, Chatellier J, Plouffe C, Lee TS, Thomas DY, Storer AC, Ménard R (1995) Structural and functional roles of asparagine 175 in the cysteine protease papain. J Biol Chem 270:16645–16652

  28. Herzog E, Frigato T, Helms V, Lancaster CRD (2006) Energy barriers of proton transfer reactions between amino acid side chain analogs and water from ab initio calculations. J Comput Chem 27:1534–1547

  29. Lill MA, Hutter MC, Helms V (2000) Accounting for environmental effects in ab initio calculations of proton transfer barriers. J Phys Chem A 104:8283–8289

  30. Lill MA, Helms V (2001) Molecular dynamics simulation of proton transport with quantum mechanically derived proton hopping rates (Q-HOP MD). J Chem Phys 115:7993–8005

  31. Davies C, Heath RJ, White SW, Rock CO (2000) The 1.8 Å crystal structure and active-site architecture of beta-ketoacyl-acyl carrier protein synthase III (FabH) from Escherichia coli. Structure 8:185–195

  32. Hol WGJ, van Duijnen PT, Berendsen HJC (1978) The α-helix dipole and the properties of proteins. Nature 273:443–446

  33. Storz MP, Brengel C, Weidel E, Hoffmann M, Hollemeyer K, Steinbach A, Müller R, Empting M, Hartmann RW (2013) Biochemical and biophysical analysis of a chiral PqsD inhibitor revealing tight-binding behavior and enantiomers with contrary thermodynamic signatures. ACS Chem Biol 8:2794–2801. doi:10.1021/cb400530d

Download references

Author contributions

AS, MCH, and MN conceived and designed the study. Semiempirical calculations were carried out by MCH. MN performed the molecular dynamics simulations. CB, CH, CZ, ME, and AS conducted the experiments. RH initiated this study. We thank Simone Amann for technical assistance and Michael Hoffmann for LC-ESI-MS measurements.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael C. Hutter.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hutter, M.C., Brengel, C., Negri, M. et al. Mechanistic details for anthraniloyl transfer in PqsD: the initial step in HHQ biosynthesis. J Mol Model 20, 2255 (2014). https://doi.org/10.1007/s00894-014-2255-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00894-014-2255-z

Keywords

Navigation